Joseph Jorizzo to Adolescent
This is a "connection" page, showing publications Joseph Jorizzo has written about Adolescent.
Connection Strength
0.419
-
Aung-Din D, Heath M, Wechter T, Cline A, Feldman SR, Jorizzo JL. Effectiveness of the Tacrolimus Swish-and-Spit Treatment Regimen in Patients With Geographic Tongue. JAMA Dermatol. 2018 12 01; 154(12):1481-1482.
Score: 0.097
-
Rattanakaemakorn P, Jorizzo JL. The efficacy of methotrexate in the treatment of en coup de sabre (linear morphea subtype). J Dermatolog Treat. 2018 Mar; 29(2):197-199.
Score: 0.088
-
Jorizzo J, Grossman R, Nighland M. Tretinoin microsphere gel in younger acne patients. J Drugs Dermatol. 2008 Aug; 7(8 Suppl):s9-13.
Score: 0.047
-
Savin R, Jorizzo J. The safety and efficacy of sertaconazole nitrate cream 2% for tinea pedis. Cutis. 2006 Oct; 78(4):268-74.
Score: 0.042
-
Hundley JL, Carroll CL, Lang W, Snively B, Yosipovitch G, Feldman SR, Jorizzo JL. Cutaneous symptoms of dermatomyositis significantly impact patients' quality of life. J Am Acad Dermatol. 2006 Feb; 54(2):217-20.
Score: 0.039
-
Sugai DY, Gustafson CJ, De Luca JF, Davis SA, Jorizzo JL, O'Rourke KS, Feldman SR. Trends in the outpatient medication management of lupus erythematosus in the United States. J Drugs Dermatol. 2014 May; 13(5):545-52.
Score: 0.018
-
Koch SB, Cerci FB, Jorizzo JL, Krowchuk DP. Linear morphea: a case series with long-term follow-up of young, methotrexate-treated patients. J Dermatolog Treat. 2013 Dec; 24(6):435-8.
Score: 0.017
-
Eichenfield LE, Jorizzo JL, Dirschka T, Taub AF, Lynde C, Graeber M, Kerrouche N. Treatment of 2,453 acne vulgaris patients aged 12-17 years with the fixed-dose adapalene-benzoyl peroxide combination topical gel: efficacy and safety. J Drugs Dermatol. 2010 Nov; 9(11):1395-401.
Score: 0.014
-
Gold LS, Cruz A, Eichenfield L, Tan J, Jorizzo J, Kerrouche N, Dhuin JC. Effective and safe combination therapy for severe acne vulgaris: a randomized, vehicle-controlled, double-blind study of adapalene 0.1%-benzoyl peroxide 2.5% fixed-dose combination gel with doxycycline hyclate 100 mg. Cutis. 2010 Feb; 85(2):94-104.
Score: 0.013
-
Smith ES, Hallman JR, DeLuca AM, Goldenberg G, Jorizzo JL, Sangueza OP. Dermatomyositis: a clinicopathological study of 40 patients. Am J Dermatopathol. 2009 Feb; 31(1):61-7.
Score: 0.012
-
Walsh SN, Jorizzo JL, Haverstock C, Sangüeza OP. A linear orofacial macule. Am J Dermatopathol. 2008 Apr; 30(2):194-5.
Score: 0.012
-
Dawn A, Thevarajah S, Cayce KA, Carroll CL, Duque ML, Chan YH, Jorizzo JL, Yosipovitch G. Cutaneous blood flow in dermatomyositis and its association with disease severity. Skin Res Technol. 2007 Aug; 13(3):285-92.
Score: 0.011
-
Parish LC, Jorizzo JL, Breton JJ, Hirman JW, Scangarella NE, Shawar RM, White SM. Topical retapamulin ointment (1%, wt/wt) twice daily for 5 days versus oral cephalexin twice daily for 10 days in the treatment of secondarily infected dermatitis: results of a randomized controlled trial. J Am Acad Dermatol. 2006 Dec; 55(6):1003-13.
Score: 0.010